FUW-tetO-lox-hSOX2 Citations (3)

Originally described in: Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.
Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R Cell. 2009 Mar 6. 136(5):964-77. PubMed Journal

---

Articles Citing FUW-tetO-lox-hSOX2

Articles
Increased genomic integrity of an improved protein-based mouse induced pluripotent stem cell method compared with current viral-induced strategies. Park H, Kim D, Kim CH, Mills RE, Chang MY, Iskow RC, Ko S, Moon JI, Choi HW, Man Yoo PS, Do JT, Han MJ, Lee EG, Jung JK, Zhang C, Lanza R, Kim KS. Stem Cells Transl Med. 2014 May;3(5):599-609. doi: 10.5966/sctm.2013-0149. Epub 2014 Apr 24. PubMed
SOX2 Drives Bronchial Dysplasia in a Novel Organotypic Model of Early Human Squamous Lung Cancer. Correia LL, Johnson JA, McErlean P, Bauer J, Farah H, Rassl DM, Rintoul RC, Sethi T, Lavender P, Rawlins EL, Littlewood TD, Evan GI, McCaughan FM. Am J Respir Crit Care Med. 2017 Jun 1;195(11):1494-1508. doi: 10.1164/rccm.201510-2084OC. PubMed
Endogenous pluripotent factor expression after reprogramming cat fetal fibroblasts using inducible transcription factors. Zhou R, Comizzoli P, Keefer CL. Mol Reprod Dev. 2019 Nov;86(11):1671-1681. doi: 10.1002/mrd.23257. Epub 2019 Aug 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.